Lukasz Szczerbinski
@l_szczerbinski
Followers
257
Following
7K
Media
9
Statuses
46
Physician-scientist | Instructor at Massachusetts General Hospital & the Broad Institute | Assistant Professor at the Medical University of Bialystok
Boston, MA
Joined July 2017
Today I had the incredible opportunity to meet one of my scientific idols,@DanielJDrucker, a pioneer in the discovery of GLP-1. We had a chance to sit down for lunch during his visit to the @broadinstitute and talk about the current state of the field. It was also great to
0
0
7
Thanks a lot for visiting us, @wagrob! We're excited to continue our ongoing collaborations and explore new projects between our labs. Looking forward to more great work ahead! 🚀.
Advancing our partnership in precision prevention and diabetes treatment with the Medical University of Bialystok. Impressive facilities and exciting studies underway! Grateful to @l_szczerbinski, Vice Rector Adam Kretowski, and the team for the warm hospitality.
0
0
5
RT @pnatarajanmd: Nice summary about @MGHMedicine Endocrine investigators transforming type 2 diabetes classification and management studyi….
0
1
0
Excited to share our latest paper, where we provide validated type 1 and type 2 diabetes definitions for the @AllofUsResearch! These algorithms are now freely available for the diabetes research community 🎉. Accurately identifying well-defined cases and.
nature.com
Scientific Reports - Algorithms for the identification of prevalent diabetes in the All of Us Research Program validated using polygenic scores
2
4
25
RT @josep_mercader: Glad to share pub @NatureGenet, shared first auth.@AliciaChagoya, Philip Schroeder, Ravi Mandla @CGM_MGH @MassGenBrigh….
nature.com
Nature Genetics - Rare variant analyses identify a new type 2 diabetes risk allele near the LEP gene, which encodes leptin, and other risk alleles of intermediate penetrance in genes previously...
0
34
0
What I love most about science is the collaboration and teamwork. Just came back from Düsseldorf, where we went with my team to meet @wagrob and his fantastic group at the DDZ. It was a great start to our collaboration, with exciting discussions about ongoing projects and future
1
0
11
Had a great time attending the EASD meeting last week! So much excellent science and productive meetings with collaborators. A special shout-out to the fantastic precision medicine in diabetes session led by @ShivaniM_KC , with amazing talks from @miriam_udler, @EmKSims and
1
0
7
RT @hsdash: The default clinical practice of 24-h continuous nutrition for critically ill patients should be reconsidered given its lack of….
ccforum.biomedcentral.com
0
2
0
It's out! 🎉 The latest article from the @miriam_udler lab has been published today in #NatureMedicine. Honored to be a part of this incredible team and to work alongside such dedicated scientists under Miriam's leadership! #DiabetesResearch #Genetics @broadinstitute @CGM_MGH.
Analyses of large cohorts of patients with type 2 diabetes identified 12 disease genetic clusters with distinct cardiometabolic trait associations, providing insights on disease susceptibility across ancestries @miriam_udler @broadinstitute @CGM_MGH
1
3
13
Queen @iga_swiatek 👑. #1GA.
Simply. Unstoppable. @iga_swiatek is your 2023 @WTAFinals CHAMPION 🎉. #WTAFinals #GNPSegurosWTAFinalsCancun
0
0
4
Thrilled to share our latest paper in @TheLancetEndo! Together with @JoseFlorezMDPhD, we delve into the advances in obesity genetics, its metabolic consequences, and the future of precision obesity management. It's time to emphasize obesity-centered diabetes care! 🧬🎯💊 #obesity.
0
6
34
RT @miriam_udler: Ever wonder why people get type 2 diabetes at different BMI thresholds? So proud of this incredible effort to generate mu….
0
16
0
RT @kirksmith628: 1/6) Type 2 diabetes (T2D) is a heterogeneous disease for which causal pathways are incompletely understood. In our new p….
medrxiv.org
We identified genetic subtypes of type 2 diabetes (T2D) by analyzing genetic data from diverse groups, including non-European populations. We implemented soft clustering with 650 T2D-associated...
0
17
0
RT @CommsMedicine: ⭐️ OUT NOW @CommsMedicine - Misra et al. conduct a systematic review of the evidence on the precision subclassification….
nature.com
Communications Medicine - Misra, Wagner et al. systematically review if strategies to subclassify type 2 diabetes (T2D) are associated with high quality evidence and patient outcomes. Cluster-based...
0
10
0
Thank you @EASDnews for the opportunity to present our results and for the award for best abstract by young scientist! Kudos to my team at @MassGeneralNews, @broadinstitute and @UMB_Bialystok, especially @josephine_h_li, @josep_mercader and @JoseFlorezMDPhD #EASD2023 #diabetes
8
4
34
Great time in Copenhagen with my team, meeting our collaborators at @UCPH_Research to discuss ongoing projects and present the first results of our oral semaglutide pharmacogenomics study (GAROS). Thanks @stelar75 for having us!
1
0
14
Congratulations @JoseFlorezMDPhD 🎉🎉 Proud to be part of your team and witness your exceptional leadership!! Exciting times ahead for the entire @MassGeneralNews community.
Incredibly honored, humbled and excited to become the next Chair of the Department of Medicine at the Massachusetts General Hospital @MGHMedicine @MassGeneralNews.
0
0
10
RT @josep_mercader: Incredible tour de force by the amazing @AliciaChagoya shows the value of TOPMed imputation in Latino cohorts. Thanks t….
0
5
0
🎉 Thrilled to join Alicia & @josep_mercader in a study using #TOPMed to analyze rare genetic variations in the Latino population. Our work highlights TOPMed's power in uncovering new T2D links & improving polygenic scores. 🧬🔬 #T2D #Genetics #Diversity.
The long uphill march to clinically useful polygenic risk scores continues #T2D #Genetics @DiabetologiaJnl
0
0
6
Thanks @AllofUsResearch for the opportunity to present our study on new algorithms for identifying diabetes in the All of Us EHR data. Shoutout to our amazing team at MGH/Broad, including our supervisors @josep_mercader , @AlisaManningPhD , and @miriam_udler #AllofUsRC2023
0
0
14